OTCMKTS:RKAGY - RHÖN-KLINIKUM Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.16
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New RHÖN-KLINIKUM Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RKAGY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RKAGY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $9.16.

N/A

The current consensus among 0 investment analysts is to n/a stock in RHÖN-KLINIKUM Aktiengesellschaft. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/15/2017Credit Suisse GroupDowngradeNeutral ➝ Underperform
i
(Data available from 6/14/2016 forward)
RHÖN-KLINIKUM Aktiengesellschaft logo
RHÃ-N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Read More

Today's Range

Now: $9.16
$9.16
$9.16

50 Day Range

MA: $9.20
$9.16
$9.25

52 Week Range

Now: $9.16
$9.16
$10.00

Volume

N/A

Average Volume

200 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RHÖN-KLINIKUM Aktiengesellschaft?

The following equities research analysts have issued reports on RHÖN-KLINIKUM Aktiengesellschaft in the last year:
View the latest analyst ratings for RKAGY.

What is the current price target for RHÖN-KLINIKUM Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for RHÖN-KLINIKUM Aktiengesellschaft in the next year.
View the latest price targets for RKAGY.

What is the current consensus analyst rating for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RKAGY.

What other companies compete with RHÖN-KLINIKUM Aktiengesellschaft?

How do I contact RHÖN-KLINIKUM Aktiengesellschaft's investor relations team?

The company's listed phone number is 49 9771 65 0. The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com.